Arkolith/Insider Trading/ABUS/Form 4

Roivant Sciences Ltd.

10% OwnerArbutus Biopharma Corp (ABUS) · full profile →Form 4 · filed Oct 20, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 18, 2021Conversion(C)22.8M——38.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 18, 2021Conversion(C)1.2M——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950103-21-016172) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML